Fundraising FoxEdulis Therapeutics
Techstars '26Nashville, US · 1 known investors
Find your way into Edulis Therapeutics
Sign up to see every warm intro you have to Edulis Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Edulis Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Edulis develops a bioresorbable, endoscopically delivered drug implant that provides sustained, controlled medication release inside the gastrointestinal tract for up to 12 months. The system targets chronic conditions such as inflammatory bowel disease (IBD) and chronic pain, aiming to improve bioavailability and reduce systemic side effects compared to oral therapies.
Investors · 1
Frequently asked questions
- What does Edulis Therapeutics do?
- Edulis develops a bioresorbable, endoscopically delivered drug implant that provides sustained, controlled medication release inside the gastrointestinal tract for up to 12 months. The system targets chronic conditions such as inflammatory bowel disease (IBD) and chronic pain, aiming to improve bioavailability and reduce systemic side effects compared to oral therapies.
- Who are Edulis Therapeutics's investors?
- Edulis Therapeutics's investors include Techstars.
- Where is Edulis Therapeutics headquartered?
- Edulis Therapeutics is headquartered in Nashville, US.